EP. 1: Dr Taylor on the Integration of Tagraxofusp Into the Frontline Treatment Armamentarium for BPDCN
April 10th 2023
Justin W. Taylor, MD, discusses the evolution of frontline treatment options for patients with blastic plasmacytoid dendritic cell neoplasm, including the integration of tagraxofusp-erzs into the treatment armamentarium in this disease space.